Protects cattle against viral and bacterial challenges associated with Bovine Respiratory Disease.
Modified live virus and killed bacterin shown to be effective for the vaccination of healthy cattle 5 months of age or older against IBR, BVD Types 1&2, PI3, BRSV, Mannheimia haemolytica and Pasteurella multocida.
Directions: 2 ml subcut followed by a dose of PULMO-GUARD PH-M in 14-28 days. Do not use in calves nursing pregnant cows. 21 day slaughter withdrawal.
Anaphylactoid reactions may occur. Antidote: Epinephrine.
Size: 10 ds, 50 ds
RESPIVAX™ 5 + PH-M Cattle Vaccine
PACKAGING RESPIVaxTM 5 + PH-M, a vaccine to protect cattle against viral and bacteria challenges associated with Bovine Respiratory Disease (BRD). A Combination respiratory vaccine that provides protection from the 5 primary viral pathogens (IBR, BVD Type 1a, Type 2, BRSV and PI3) and the key bacterial pathogens (Mannheimia Haemolytica and Pasteurella multocida) in a bacterin-toxoid. RESPIVax 5 + PH-M - 10 ds (20 mL) vial RESPIVax 5 + PH-M - 50 ds (100 mL) vial This product has been shown to be effective for the vaccination of healthy cattle five months of age or older against Infectious Bovine Rhinotracheitis, Bovine Viral Diarrhea Virus Type 1a, Bovine Viral Diarrhea Virus Type 2, Parainfluenza3 Bovine Respiratory Syncytial Virus, Mannheimia Haemolytica and Pasteurella Multocida. Duration of Immunity for this product has not been determined. For more information regarding efficacy and safety data, see productdata.aphis.usda.gov. INDICATIONS STORAGE Store at 2 ºC (35.6ºF) to 8ºC (46.4ºF). MIXING DIRECTIONS AND USES Aseptically rehydrate the freeze-dried modified live vaccine with the accompanying bottle of bacterintoxoid, shake well, and administer 2 mL subcutaneously in the side of the neck followed by a second dose of Mannheimia Haemolytica – Pasteurella Multocida (Pulmo-Guard® PH-M) to be given 14 to 28 days after the first dose. CAUTIONS Huvepharma, Inc. • 525 Westpark Drive, Suite 230, Peachtree City, GA 30269 • tel.: 877-994-4883 • fax: 770-486-7217 • firstname.lastname@example.org HVP-RESPI5PHM-PDS-01.20 RESPIVax is a trademark of Huvepharma, Inc. RESPIVax ™ 5 + PH-M Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza3 - Respiratory Syncytial Virus Vaccine, Modified Live Virus, Mannheimia Haemolytica-Pasteurella Multocida Bacterin-Toxoid Do not vaccinate pregnant cows. Do not use in calves nursing pregnant cows. Abortions may result. Store at 2º to 8ºC. Use entire contents when first opened. Inactivate unused contents before disposal. Do not vaccinate within 21 days of slaughter. In case of anaphylactoid reaction treat symptomatically. Do not mix with other products, except as specified on this label. In case of human exposure, contact a physician. This product contains Neomycin, Nystatin, and Thimerosal as preservatives. For Veterinary Use Only. DIRECTIONS Aseptically rehydrate the freeze-dried modified live vaccine with the accompanying bottle of bacterin toxoid, shake well, and administer 2 mL subcutaneously in the side of the neck followed by a second dose of Mannheimia Haemolytica – Pasteurella Multocida (Pulmo-Guard® PH-M) to be given 14 to 28 days after the first dose. Product BVD Type 1a & 2 IBR PI3 BRSV M. haemolytica P. multocida RESPIVax 3 RESPIVax 3+PH-M RESPIVax 5 RESPIVax 5+PH-M w w w.h u v e p h arm a.us